Rania Mhenni , Sarah Dellière , Chiheb Ben Maaouia , Samia Hamane , Benjamin Deniau , Thibault Mahévas , Maité Chaussard , Maxime Coutrot , Lucie Guillemet , Alexandru Cupaciu , Alexandre Pharaboz , Thais Walter , Louis Boutin , Mourad Benyamina , Hélène Corte , Charles Delale , Marc Chaouat , Amélie Guihot , Fanny Lanternier , Alexandre Alanio , Emmanuel Dudoignon
{"title":"Combined antifungal therapy with immunostimulation for refractory cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus","authors":"Rania Mhenni , Sarah Dellière , Chiheb Ben Maaouia , Samia Hamane , Benjamin Deniau , Thibault Mahévas , Maité Chaussard , Maxime Coutrot , Lucie Guillemet , Alexandru Cupaciu , Alexandre Pharaboz , Thais Walter , Louis Boutin , Mourad Benyamina , Hélène Corte , Charles Delale , Marc Chaouat , Amélie Guihot , Fanny Lanternier , Alexandre Alanio , Emmanuel Dudoignon","doi":"10.1016/j.diagmicrobio.2024.116653","DOIUrl":null,"url":null,"abstract":"<div><div>Mucormycosis is a fungal infection typically affecting immunocompromised patients. Here, we report a severe case of invasive cutaneous and peritoneal mucormycosis caused by <em>Rhizopus microsporus</em>, successfully treated with a combination of antifungal therapy, PD-1 inhibitor, and interferon-gamma. We highlight the importance of personalized immunotherapy in refractory cases of invasive mucormycosis.</div></div>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"111 3","pages":"Article 116653"},"PeriodicalIF":2.1000,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic microbiology and infectious disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0732889324004772","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Mucormycosis is a fungal infection typically affecting immunocompromised patients. Here, we report a severe case of invasive cutaneous and peritoneal mucormycosis caused by Rhizopus microsporus, successfully treated with a combination of antifungal therapy, PD-1 inhibitor, and interferon-gamma. We highlight the importance of personalized immunotherapy in refractory cases of invasive mucormycosis.
期刊介绍：
Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
